XIth Eurasian Hematology-Oncology Congress - EHOC 2020
T

Pros and Cons of Generic Drugs: What Are the FDA Approval Requirements and Why Do We Need Generic Drugs? Why Is Quality Control Important?

By XIth Eurasian Hematology-Oncology Congress - EHOC 2020 FEATURING Tomasz Sacha
By XIth Eurasian Hematology-Oncology Congress - EHOC 2020 FEATURING Tomasz Sacha
27 views
January 12, 2021
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
Cleveland Clinic Respiratory Institute

Advanced Diagnostic Bronchoscopy Workshop

Fri, Jun 14, 2024
Fox Chase Cancer Center

2024 Atlantic Regional Hematopathology Meeting

Sat, May 11, 2024
Penn Medicine Abramson Cancer Center

Updates in Oncology 2024 Philadelphia: with Proceedings from Interna…

Wed, Jun 12, 2024
UChicago Medicine

27th University of Chicago Comprehensive Cancer Center Developmental…

Fri, May 10, 2024
Vanderbilt University Medical Center (VUMC)

Vanderbilt Stem Cell Transplant and Cellular Therapy Symposium

Sat, May 11, 2024
Yale Cancer Center

Gastrointestinal Cancer CME Series: Gastroesophogeal Cancer

Thu, May 23, 2024
See 1 other
COR2ED The Heart of Medical Education

Precision Oncology in Practice - The Journey from Testing to Treatme…

Tue, Apr 30, 2024
See 1 other
European Research Initiative on CLL - ERIC

ERIC International Meeting 2024 - New Frontiers in CLL Research

Thu, Sep 26, 2024
i3 Health

Live Webinar: Hitting the Target in HER2-Positive Metastatic Colorec…

Mon, Apr 29, 2024
See 2 others
MI&T Congressi

3rd International Summit on Lung Cancer

Sun, May 5, 2024
SOHO Brazil

SOHO Brazil 2024

Thu, May 16, 2024
Total Health

MDONS Metro Denver Chapter Conference

Fri, May 17, 2024
12:48
ASCO GU 2023 Conference Coverage

Cost-Effectiveness Analysis of Seven Treatment Regimens in mHSPC: A …

Feat. M. Kohli
03:45
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Risk of Early Mortality in Patients With …

Feat. H. Khan
11:51
ecancer

The Common Sense Movement in Oncology

Feat. V. Vanderpuye
15:30
ecancer

Radiotherapy and Oncology: Choosing Wisely

Feat. M. Mushonga
18:40
OncoAlert

SWOG Solid Cancer Trials in 2022

Feat. C. Blanke
03:22
GRACE

Barriers to Biomarker Testing: Cost and Insurance

Feat. A. Desai
51:13
RWJBarnabas Health Rutgers Cancer Institute of New Jersey

Advances in Surgical Care of the Oncology Patient: Panel Discussion

Feat. R. Alexander, J. Aikins, J. Benevenia, R. Lazzaro, T. Beninato, M. Kohli
64:43
Scripps MD Anderson Cancer Center

Navigating Insurance Challenges in Cancer Care

Feat. S. Bottomley
05:51
ecancer

ASCO®'s Strategic Plan for Cancer Care in Low- and Middle-Incom…

Feat. L. Schuchter
07:31
SGO 2022 Conference Coverage on VuMedi

SGO 2022 on Pembrolizumab for Persistent, Recurrent, or Metastatic C…

Feat. D. Barrington
22:29
2023 West Oncology Conference

Clinical Research: Shortening the Gap and Improving Representation

Feat. A. Loaiza-Bonilla
40:16
Hope for Stomach Cancer

Triage Cancer: Navigating Health Insurance & Managing Medical Bi…

Feat. J. Fawzy Doran
11:15
Gary Lyman

The Evolving Biosimilars Revolution in Oncology: Why Interest in Bio…

02:41
GRACE

Targeted Therapies in Lung Cancer 2023: Barriers to Biomarker Testin…

Feat. A. Desai
09:05
Total Health

Financial Toxicity in Cancer Care as Barriers to Access

Feat. A. Liddell
40:03
2021 Community Oncology Conference

How to Maximize Practice Efficiencies and Reduce Costs: What Your Pr…

Feat. B. Gamble, M. Neubauer, T. O’Connell, A. Rahman
15:02
Bernardo Goulart

Financial Toxicity of TKIs in NSCLC: Impact of TKI Out-of-Pocket Cos…

17:28
2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer

Overview of Biosimilars in Oncology: What Are They and How They Fit …

Feat. M. Aapro
12:30
Timothy Hanna

WCLC 2021: Barriers for Access to Curative Lung Cancer Treatment and…

15:44
2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer

2019 Overview of Current Guidelines on the Use of Biosimilars

Feat. H. Dhillon